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the expression of miR-15/107 family miRNAs, we employed customized TaqMan Low-Density
micro-ﬂuid PCR-array to investigate the expression of miR-15/107 family members, and other
selected miRNAs, in 11 human tissues obtained at autopsy including the cerebral cortex, frontal
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cle. miR-103, miR-195 and miR-497 were expressed at similar levels across various tissues, whereas
miR-107 is enriched in brain samples. We also examined the expression patterns of evolutionarily
conserved miR-15/107 miRNAs in three distinct primary rat brain cell preparations (enriched for
cortical neurons, astrocytes and microglia, respectively). In primary cultures of rat brain cells, sev-
eral members of the miR-15/107 family are enriched in neurons compared to other cell types in the
central nervous system (CNS). In addition to mature miRNAs, we also examined the expression ofon PT).
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20 Genomics Proteomics Bioinformatics 12 (2014) 19–30precursors (pri-miRNAs). Our data suggested a generally poor correlation between the expression
of mature miRNAs and their precursors. In summary, we provide a detailed study of the tissue and
cell type-speciﬁc expression proﬁle of this highly expressed and phylogenetically conserved family of
miRNA genes.Introduction
MicroRNAs (miRNAs) are short non-coding RNAs that are
expressed in all known plant and animal cells. MiRNAs are
estimated to regulate the translation of well over half the tran-
scripts in the human genome [1–3]. Derived from a larger RNA
precursor (pri-miRNA), the miRNA transcript is processed in
a multistage sequence, culminating in the cleavage of a short
hairpin RNA to form a mature 22 nucleotide miRNA [4].
In animal species, miRNAs regulate gene expression at the
post-transcriptional level, via imperfect sequence complemen-
tarity with ‘‘target’’ mRNA, which results in either mRNA
translational suppression or degradation [5]. An essential reg-
ulatory portion of mature miRNA is the ‘seed’ region near the
50 end of a miRNA [1,6].
The focus of the current study is a group of paralogous,
evolutionarily-conserved miRNAs termed the miR-15/107
family [7–9]. This group of miRNAs shares a sequence (AG-
CAGC) near the 50 end [7] that complements with an overlap-
ping list of mRNA targets [10,11]. Members of the miR-15/107
family play key roles in gene regulation involved in cell divi-
sion, metabolism, stress response and angiogenesis [7]. The
miR-15/107 group has been implicated in pathological pro-
cesses including cancers, cardiovascular disease and neurode-
generative diseases. While all vertebrates examined to date
express miR-15a, miR-15b, miR-16, miR-103 and miR-107,
only mammals are known to express miR-195, miR-424,
miR-497, miR-503, whereas miR-646 appears to be human-
speciﬁc [7].
Among the key characteristics of any miRNA are the
types of tissues and cells where a speciﬁc miRNA is ex-
pressed. Thus, miRNA expression proﬁling is an essential
tool for understanding which genes are transcribed (pri-miR-
NAs) and processed to mature miRNAs in various organs
and cells. Although there have been prior expression proﬁl-
ing studies of miRNAs in human tissues (see below), the
particular expression proﬁles of all miR-15/107 family genes
have not been thoroughly described either in human tissues
or in terms of the speciﬁc cell types of the central nervous
system (CNS). To address this, we examined and here report
on the expression of miR-15/107 miRNAs in both human
tissues and in individual cell types of the cultured rat brain
cell preparations. This study also presents data using a
relatively novel RT-qPCR-based method for miRNA
quantitation.Results
miR-15/107 family miRNAs are highly expressed in human
brain with overlapping targets
Mature miRNAs of miR-15/107 family share a sequence (AG-
CAGC) near the 50 end (Figure 1A), and multiple familymembers are expressed at high levels in the human brain tissue
(Figure 1B). Analysis of RNA deep sequencing data generated
from human brains [12] revealed that miR-15/107 family
accounts for 1.5–2.0% of total miRNA reads in the temporal
neocortex (Brodmann areas 21/22) gray matter of non-demen-
ted control brains. From RNA isolated from these human
brain samples, miR-16, miR-103, miR-107 and miR-497 are
the most highly expressed miRNAs among the family mem-
bers. Biochemical identiﬁcation of miR-16, miR-103, miR-
107 and miR-497 targets in H4 glioneuronal cell line showed
that these miRNAs share high degrees of overlap in targets
(Figure 1C) with 20% of mRNA targets shared by all 4
miRNAs.
Multiple mature miRNAs of miR-15/107 family members show
robust expression in different human tissues
A custom designed PCR-array panel was used, including 10
miR-15/107 members and the other 10 selected miRNAs
(Table S1) to proﬁle the miRNA expression from 11 human
tissues. Demographic information on the human autopsied
cases is provided in Table S2. Relatively high levels of miRNA
expression were observed across different human tissues with
PCR Ct values ranging from 15 (miR-16) to 35 (miR-646)
(Figure 2) in some tissue samples. Hierarchical clustering
(Pearson’s correlation-Average Linkage) based on the similar-
ity of miRNA expression patterns of the 11 tissues demon-
strated that similar anatomical tissues were generally
clustered together. For example, cerebral cortex, frontal cortex
and primary visual cortex showed similar miRNA expression
pattern, resulting in close clustering; similarly, heart and skel-
etal muscle samples demonstrated similar expression patterns.
The heat map also showed a clustering of miRNA expression
pattern for a given tissue type (between cases), indicating an
organ-speciﬁc expression pattern. For detailed quantitative
data, see Tables S3 and S4.
Further analysis revealed a distinct expression proﬁle of
brain-enriched miRNAs (Table 1 and Figure 3). For example,
miR-124a, a known brain-enriched miRNA, was strongly ex-
pressed in brain tissues as expected with lower levels of expres-
sion in the kidney, spleen and skeleton muscle samples
(expression marked as ‘‘undetectable’’ when Ct > 35). miR-
107 was also shown to be enriched in brain tissues (3.25-fold,
P< 0.0001). Similarly miR-103 and Let-7a tended to be ex-
pressed at higher levels in brain tissues, whereas miR-16,
miR-15a, miR-15b, miR-424, miR-497, miR-503, miR-646
and other non-miR-15/107 miRNAs (miR-20a, miR-23a,
miR-27a, miR-27b, miR-30d, miR-143) tended to show higher
expression in non-brain tissues (Figure 3 and Table 1). Com-
parison of miRNA expression among individual tissue types
showed that miR-15a, miR-15b and miR-16 were enriched in
the spleen, miR-424 was expressed relatively high in the kid-
ney, liver and skeletal muscle, and miR-646 was enriched in
the kidney.
Figure 1 Highly expressed miR-15/107 miRNAs with overlapping targets
A. Members of miR-15/107 share a homologous 50 sequence. Shown here are the miR-15/107 miRNAs that are highly expressed in
human tissues. B. Normalized miRNA reads for miR-15/107 family from deep sequencing RNA-seq data. RNA was prepared from
two cognitively intact persons’ temporal lobe brain samples [12]. C. Biochemical identiﬁcation of miR-16, miR-103, miR-107 and
miR-497 targets according to methods previously published [49,50] revealed extensive but non-identical overlapping targets in H4
cells. This not only shows the importance of the ‘seed’ regions, but also indicates that non-seed portions of the miRNAs are
important as well. In this assay, 18,761 mRNAs were not targeted by any of these miRNAs.
Wang WX et al / Expression of miR-15/107 Family 21Members of the miR-15/107 family are enriched in neurons
The expression of miR-15/107 family miRNAs was evalu-
ated in different brain cell types. Primary rat neuron, astro-
cyte and microglia cultures were obtained from rat pups at
embryonic day 18 (E18) (see Materials and methods). The
cell-type enriched cultures were veriﬁed by Western blot
analysis using antibodies against cell-type speciﬁc markers
(Figure 4).
The expression of all tested miRNAs was different between
neuronal (cerebral cortical neurons) and non-neuronal (cere-
bral cortical astrocytes and microglial) cells (Figures 5 and 6,
Table 2). In contrast, astrocytes and microglial share relatively
similar expression proﬁles (Table 2). Speciﬁcally, 4 members of
the miR-15/107 family (miR-103, miR-107, miR-195 and
miR-497) were among the neuron-enriched miRNAs (>2-fold
enriched for each, P< 0.05). Other neuron-enriched miRNAs
include miR-124, miR-20a, miR-320 and Let-7a miRNAs
(Figures 5 and 6, Table 2), whereas miR-23a, miR-27a,
miR-29a, miR-29b and miR-143 were glial-enriched (both
P< 0.05).Expression of pri-miRNAs is correlated relatively weakly with
that of mature miRNAs in miR-15/107 family
Diverse expression proﬁles were found for miRNA precursors
(pri-miRNA) in human tissues (Figure 7 and Table S5). The
expression of miR-124 precursor was exclusively identiﬁed inthe brain tissues, which is well correlated with its neuronal
expression characteristics. In contrast, miR-23a precursor
was expressed at relatively high levels in non-brain tissues
(Table 3).
Correlations between expression of the fully processed
(22 nt, i.e., ‘‘mature’’) miRNA and precursor transcript
expression were generally not strong for most miRNAs
(Table 4 and Figure S1). Among the 23 miRNAs tested,
miR-124, a brain and neuron-speciﬁc non-miR-15/107 family
miRNA, showed the strongest correlation (R2 = 0.9189) be-
tween precursor and mature miRNA. The mature miR-103
can potentially be generated from two primary miRNA tran-
scripts that are encoded from different chromosomes [13].
The array data showed that expression of mature miR-103
shows a tighter correlation with miR-103a-2 precursor (hsa-
miR-103a-2-Hs03302758_pri, Table 4 and Figure S1), which
was expressed at relatively high levels across all tested tissues.
The expression levels of miR-103a-2 precursor were higher
than that of miR-103a-1 (fold increase of 1.8–72.8, Table 5).
These data indicate that mature miR-103 in humans appears
to be mainly generated from miR-103a-2 precursor that re-
sides in PANK2 gene.
We also examined the expression of some non-miR-15/107
miRNA genes. The human miR-29 family includes three ma-
ture members, miR-29a, miR-29b and miR-29c, that are en-
coded by two gene clusters. The gene encoding the
precursors of both miR-29b-1 and miR-29a is located on
Chromosome 7, whereas the coding gene for both miR-29b-
2 and miR-29c is on Chromosome 1 [14]. Among the three
Figure 2 Hierarchical clustering of miRNA expression in human tissues
Ct values of each assay were normalized using the global mean method. The average linkage of the clustered group was calculated using
the Pearson’s correlation method. Tissues of the same or similar anatomic origin were clustered together, indicating discernible tissue-type
speciﬁc expression patterns for these miRNAs. Each tissue groups were marked in the same colors. CECTX-L, cerebral cortex (left);
FCTX-L, frontal cortex (left); PVCTX-L, primary visual cortex (left); THY, thymus; HRT, heart; LNG-L, lung (left); LVR, liver; KID-L,
kidney (left); SPL, spleen; STO, stomach; SKMSCL, skeletal muscle.
Table 1 Relative expression of mature miRNAs in the human
brain tissue
miRNA Fold change P value
hsa-let-7a 1.63 0.0233
hsa-miR-103 1.73 0.0003
hsa-miR-107 3.25 0.0000
hsa-miR-124a 978.04 0.0000
hsa-miR-143 0.120 0.0000
hsa-miR-15a 0.481 0.0001
hsa-miR-15b 0.272 0.0000
hsa-miR-16 0.295 0.0000
hsa-miR-195 0.588 0.021
hsa-miR-20a 0.222 0.0000
hsa-miR-23a 0.196 0.0008
hsa-miR-27a 0.165 0.0004
hsa-miR-27b 0.498 0.0003
hsa-miR-29a 0.935 0.6897
hsa-miR-29b 0.645 0.1147
hsa-miR-29c 0.962 0.7846
hsa-miR-30d 0.334 0.0000
hsa-miR-320 0.719 0.1871
hsa-miR-424 0.107 0.0001
hsa-miR-497 0.769 0.1212
hsa-miR-503 0.144 0.004
hsa-miR-646 0.375 0.0524
Note: Expression of miRNAs in the human brain tissue is normalized
to that in non-brain tissues and presented as fold change. Expression
that is signiﬁcantly higher or lower in brain is highlighted in red and
green, respectively (P< 0.05). Members of miR-15/107 family are
highlighted in blue.
22 Genomics Proteomics Bioinformatics 12 (2014) 19–30miR-29 precursor transcripts tested (due to limited number of
gene spots on the array card, miR-29b-2 was not included),
primary miR-29b-1 (hsa-miR-29b-1-Hs03302748_pri) seemed
to be the major expresser in most tissues (Table S6). In con-
trast to much higher levels of mature miR-29a and miR-29c,
expression of miR-29a precursor was not detected (Ct > 40)
in the kidney, liver and spleen; likewise, expression of miR-
29c was not detected in lung and spleen. This is interesting
because miR-29a and miR-29b-1, like miR-29b-2 and miR-
29c, are apparently co-transcribed as polycistronic primary
transcripts [15].
Discussion
Here we report for the ﬁrst time a systematic expression anal-
ysis of all miR-15/107 genes in various human tissues and in
different rat CNS cell types. Individual members of the miR-
15/107 group are expressed at medium-to-high levels across
many tissue types but there is some tropism in terms of both
tissue- and cell type-speciﬁc expression. While these data pro-
vide novel results about the expression of miR-15/107 genes,
there is not, among these miRNAs, a sharply tissue- or cell-
speciﬁc miR-15/107 gene. Since miR-15/107 miRNAs (like
many other miRNAs that have co-evolved with paralogs) co-
exist alongside highly-expressed miRNAs with overlapping
targets [7,16], these data provide support to the idea that it is
necessary to take into account the expression and activities
Fold increase > 2, P < 0.05 Fold change < 2 or P > 0.05Fold decrease > 2, P < 0.05
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Figure 3 Expression proﬁles of miRNAs in different human tissues
Levels of miRNA expression in each individual tissue were calculated as fold difference against the other tissues examined. Bars in red
indicated a signiﬁcantly higher expression level (>2-fold), and bars in green indicated a signiﬁcantly (P< 0.05) lower expression level
(>2-fold) compared to the other tissues. Expression showing no statistical difference between a particular tissue type and the others was
indicated in blue.
Wang WX et al / Expression of miR-15/107 Family 23of paralogous miRNAs, rather than just focusing on individual
miRNAs in isolation.
There are some technical caveats to our study. Much of
the data derive from human subjects who came to autopsy.
This experimental approach introduces potential biases such
as those related to agonal events, comorbidities and ascer-
tainment/recruitment bias. RNA from autopsy specimens
can also be degraded. An alternative approach would have
been to use surgical pathologic specimens from multiple dif-
ferent individuals. This approach would have introduced a
separate but overlapping list of potential pitfalls such as epi-
phenomena linked to surgery (anesthesia-related RNA
expression changes), additional inter-individual variability
and strong ascertainment biases. For example, persons
undergoing stomach surgery differ systematically from those
undergoing liver surgery. Faced with the alternatives, using
autopsy material is defensible, but the data should be ana-
lyzed with caution in light of these concerns. In addition
to the pre-analytical potential challenges, researchers from
many laboratories have now found that miRNA proﬁlingresults obtained using different platforms can vary
dramatically for individual miRNAs despite good overall in-
ter-platform correlation [17–21].
Keeping the technical challenges in mind, our data pro-
vide new insights into the expression of the miR-15/107
gene family in humans. A straightforward observation is
that the miRNAs with highest expression in human tissues
(miR-15a, miR-15b, miR-16, miR-103, miR-107 and
miR-195) all include a 7-nt common sequence: AGCAGCA
(Figure 1). Our study is not able to assess different devel-
opmental stages where alterations are known to occur in
terms of miR-15/107 family member expression. For exam-
ple, miR-15 and miR-16 expression correlates to particular
stages in erythropoiesis [22,23]. Assessing archival human
brains that had been formalin-ﬁxed and parafﬁn-embedded,
we found that miR-16 expression is highly expressed during
early human brain development [24].
The current study conﬁrms some of the prior observa-
tions with regard to miR-15/107 expression proﬁling exper-
iments: gene expression among miR-15/107 group members
Table 2 Relative expression of miRNAs in primary rat neuronal
and microglial cultures
miRNA 
Microglia Neurons 
Fold change P value Fold change P value
hsa-let-7a 0.781 0.023 1.880 0.028 
hsa-miR-103 1.450 0.062 3.270 0.029 
hsa-miR-107 0.840 0.383 4.020 0.005 
hsa-miR-124a 2.900 0.137 8541.360 0.001 
hsa-miR-143 0.036 0.028 0.008 0.003 
hsa-miR-15a 1.240 0.428 2.050 0.021 
hsa-miR-15b 0.441 0.112 1.140 0.333 
hsa-miR-16 1.380 0.175 2.240 0.006 
hsa-miR-195 0.208 0.009 1.490 0.183 
hsa-miR-20a 1.150 0.244 5.320 0.001 
hsa-miR-23a 1.710 0.001 0.114 0.000 
hsa-miR-27a 1.320 0.137 0.123 0.002 
hsa-miR-27b 1.370 0.310 0.599 0.097 
hsa-miR-29a 0.926 0.298 0.091 0.003 
hsa-miR-29b 1.460 0.009 0.093 0.014 
hsa-miR-29c 1.270 0.110 0.311 0.134 
hsa-miR-30d 4.910 0.006 3.130 0.009 
hsa-miR-320 0.379 0.001 1.430 0.101 
hsa-miR-424 0.746 0.428 0.676 0.333 
hsa-miR-497 0.071 0.023 2.670 0.000 
hsa-miR-503 1.500 0.298 0.971 0.953 
Note: Expression of miRNAs in cultured rat neurons or microglial
cells is normalized to that in astrocyte preparation and presented as
fold changes. Expression that is signiﬁcantly higher or low in neurons
or microglial cells is highlighted in red and green, respectively
(P< 0.05). Members of miR-15/107 family are highlighted in blue.
24 Genomics Proteomics Bioinformatics 12 (2014) 19–30tends not to be purely speciﬁc to particular tissues or cell
types. Furthermore, despite the caveat that Ct values of
qPCR analyses cannot be conﬁdently compared across tran-
scripts, in humans the highest-expressing miRNAs tend to
be miR-15a, miR-15b, miR-16, miR-103 and miR-107.
The more recently evolved miRNAs (miR-424 and the pri-
mate-speciﬁc miR-646) show relatively low expression but
the mammal-speciﬁc miR-195/miR-497 (physically close to
each other on Chromosome 17) have moderate expression
levels.
There has been inconsistency among prior studies in terms
of miR-15/107 gene group member expression proﬁling in
mammals, possibly due to technical issues. A subset of these
miRNA genes has been detected in mammalian tissues includ-
ing heart, skeletal muscle, brain, lung, liver, kidney, spleen and
placenta [25–31]. There may be similar expression proﬁles
among some group members across human tissues (miR-15,
miR-16 and miR-195) [27], although some but not all studies
have indicated that miR-15/miR-16 expression is relatively
high in hematopoietic cells including T lymphocytes
[25,26,28,32–35].We found evidence to support miR-107 expression
tropism for the human brain, and also rat neurons versus
other cell types. Prior studies have provided mixed perspec-
tives on whether miR-107 levels are highest in brain [27–
29,31,35–37]. The complexity of this situation is illustrated
in a study of embryos from different species using miRNA
in situ hybridization, ﬁnding that miR-107 is essentially
brain-speciﬁc in the Japanese killiﬁsh, highly expressed in
almost all tissues in chicken, but neither pattern is observed
in mouse [38].
Assessment of pri-miRNA levels using qPCR provided a
new perspective on the rather poor correlation between lev-
els of mature miRNAs and their precursors. This basic
observation had been made previously by others in the con-
text of miR-103 and miR-107 precursors [37] in mice tis-
sues. We also note that miR-103a-2 appears much more
highly expressed than miR-103a-1 in all human tissues, sug-
gesting that this gene is the more transcriptionally active
source of mature human miR-103. The discordant correla-
tions of miRNA and the precursor were also reported for
other miRNAs [39]. These observations conﬁrm the impor-
tance and regulatory relevance of the processing steps of
miRNA biogenesis. In contrast to the generally discordant
correlation between levels of detected precursor and mature
miRNA, expression of miR-124 seems to be highly corre-
lated between mature and precursor – the brain-speciﬁc
expression of miR-124a [40] has been demonstrated previ-
ously [39,40].
One key point that is strongly underscored by our data is
that in a paralogous miRNA family, the cumulative impact
of those miRNAs must be addressed rather than only focusing
on one single gene family member. In other words, since
miR-15/107 miRNAs have highly overlapping targets
[7,16,41], and multiple members of the gene family are tran-
scribed at constitutively high levels, any therapeutic or diag-
nostic method based on one family member must also take
into account the biological activities of other family members.
We conclude that this added level of complexity, related to
multiple paralogs with overlapping targets, is particularly
important in miR-15/107 family of miRNAs.
TaqMan assays developed for miRNA detection and val-
idation proved to be sensitive and easy to use [42]. The more
recent TaqMan PCR-array platform is a reproducible meth-
odology in miRNA proﬁling with a broad dynamic range.
In this study, we used TaqMan’s Low Density Arrays
(TLDA) which is a medium-throughput method of real-time
RT-PCR array. This system offers ﬂexibility to tailor the
probe groups, such as the one we employed here for miR-
15/107 family proﬁling.
There is a persistent challenge of normalization in miRNA
expression studies across cell types and tissues [43–47]. We
hypothesize it may not be possible to ﬁnd a ‘‘one size ﬁts
all’’ normalization method. Although the custom array card
included internal controls (U6 and RNU66 for mature
miRNAs; beta-actin and GAPDH for the precursors) in the
panel, we could not rely on these controls to normalize the
data because of the substantial variability of these genes
expressed in tissues and cells (Tables S3, S4 and S5). In
mature miRNA panels, the standard deviations for U6 and
RNU66 are 2.1 and 2.5 Ct, respectively (equivalent to
4.3- and 5.7-fold difference); and in the miRNA precursor
panel, the standard deviations for beta-actin and GAPDH
Tau
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Neuron Astrocyte Microglia
Figure 4 Western blot veriﬁcation of different primary rat brain
cell cultures
Cell lysates of primary rat cell preparations enriched for cortical
neurons, astrocytes or microglia cells were separated on SDS–
PAGE and transferred to nitrocellulose membrane. Western blot
analysis was carried out using cell marker antibodies: anti-NeuN
monoclonal antibody (neuronal marker), anti-MAP-Tau antibody
(neuronal marker), anti-GFAP polyclonal antibody (astrocyte
marker) and anti-Iba-1-polyclonal antibody (microglia marker).
Figure 5 Hierarchical clustering of miRNA expression in primary rat
Ct values were normalized using the global mean method. The average
correlation method. The heat map demonstrated the characteristic exp
such as miR-124a, are almost exclusively expressed in neuronal cells. I
and miR-143) are enriched in cultured glial preparations. Same cell ty
Wang WX et al / Expression of miR-15/107 Family 25are 3.4 and 4.0 Ct, respectively (equivalent to 10.6- and
16-fold difference). The global mean normalization method
[48] used in our dataset appeared to represent a best ﬁt for
the dataset after further validation on selected individual miR-
NAs. When normalizing TLDA data, one should take into
consideration the careful choices of speciﬁc internal controls
for normalization to avoid technical bias.Materials and methods
High-throughput method for miR-15/107 target identiﬁcation
Experiments were performed as described in detail previously
[49,50]. Brieﬂy, H4 cells (American Type Culture Collection,
Manassas, VA) were cultured under the vendor’s recom-
mended conditions. Cells were transfected with 25 nM of exog-
enous RNA duplexes (Ambion, Austin, TX), using
RNAiMAX (Invitrogen, Carlsbad, CA) according to manu-
facturer’s instructions, and harvested 48 h after transfection.
Total RNA was isolated, reversely transcribed to cDNA forcells
linkage of the clustered group was calculated using the Pearson’s
ression patterns of miR-15/107 family miRNAs. Other miRNAs,
n contrast, some miRNAs (miR-23a, miR-27a, miR-29a, miR-29b
pes were marked in the same colors.
26 Genomics Proteomics Bioinformatics 12 (2014) 19–30expression proﬁling using Affymetrix 1.0 ST Gene microarrays
according to manufacturer’s instructions. A total of 21,898
annotated genes were proﬁled. Genes were evaluated and
determined to be targets when mRNA expression levels were
lower in relative to the negative control miRNA transfections
(N= 3 biological replicates for each transfection, P< 0.01 by
Student’s t-test).
Human tissues
All sample collection and experimental procedures involving
human subjects were in compliant with the University of
Kentucky Institutional Review board (IRB) protocols. Ele-
ven human tissues from three autopsied individuals, coded
as Case2, Case5 and Case7, with relatively intact RNA, were
used in this work. Information on the autopsied individuals
is shown in Table S2. Tissues included the cerebral cortex
(left) (CECTX-L), frontal cortex (left) (FCTX-L), primary
visual cortex (left) (PVCTX-L), thymus (THY), heart
(HRT), lung (left) (LNG-L), liver (LVR), kidney (left)
(KID-L), spleen (SPL), stomach (STO) and skeletal muscle
(SKMSCL). The heart tissue of Case5 was not available.
The samples from each tissue type were obtained with fresh
scalpels, snap-frozen in liquid nitrogen and stored at
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Animal handling was conducted following the University’s
Institutional Animal Care and Use Committee (IACUC)
protocols. Primary cortical neuronal culture, primary astro-
cyte and microglial cultures (all are cell-type enriched, rather
than pure preparations) were generated from Sprague–Daw-
ley rat pups at E18 as described in [51,52]. All primary cell
cultures were maintained at 37 C in humidiﬁed, CO2 (5%)
incubator.RNA isolation
Total RNA was extracted from human tissues or primary rat
neuron, astrocyte and microglia cells using TRIZOL LS re-
agent (Life Technologies, USA) following the modiﬁed proce-
dure described previously [18,47].
Western blot analysis
Conventional SDS–PAGE and Western blot analysis was
performed as described previously [11]. Antibodies used in
this work include anti-NeuN monoclonal antibody (neuronal
marker, Chemicon, MAB377), anti-MAP-Tau antibodymiR-124a 
miR-103 
miR-320 
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Figure 7 Hierarchical clustering of pri-miRNA expression
Ct values were normalized using global mean method in 11 human tissues. The average linkage of the clustered group was calculated using
the Pearson’s correlation method. Each tissue group was marked in the same color. CECTX-L, cerebral cortex (left); FCTX-L, frontal
cortex (left); PVCTX-L, primary visual cortex (left); THY, thymus; HRT, heart; LNG-L, lung (left); LVR, liver; KID-L, kidney (left);
SPL, spleen; STO, stomach; SKMSCL, skeletal muscle.
Wang WX et al / Expression of miR-15/107 Family 27(neuronal marker, generously provided by Dr. Peter Davies),
anti-GFAP polyclonal antibody (astrocyte marker, Sigma,
G9269), anti-Iba-1 polyclonal antibody (microglia marker,
Wako, 016-20001) and anti-beta-actin antibody (Rockland,
600401886).
miR-15/107 family proﬁling
We employed TaqMan Low-Density Array (TLDA) quantita-
tive RT–PCR assays (Life Technologies) to study miRNA
expression. Two panels of 24 assays each (Table S1) for mature
miRNAs and their precursors including two endogenous con-
trols (mammalian U6 and RNU66 for mature miRNA panel;
beta-actin and GAPDH for the precursor panel), 10 members
of miR-15/107 family and 12 other selected miRNAs, were
custom prepared as an 8 · 24 array format (384 wells with 8
samples · 24 duplicate assays in each array card). Speciﬁc
stem–loop primers for each mature miRNA were pooled and
supplied by Life Technologies for reverse transcription (RT)
reactions.
Total RNA (100 ng) was used for cDNA synthesis. For
mature miRNA array, ﬁrst-strand cDNA was synthesized
using TaqMan MicroRNA Reverse Transcription Kit (Life
Technologies) with the pooled speciﬁc stem-loop primers.
For miRNA precursor array, total RNA was ﬁrst subjected
to DNase treatment using Ambion TURBO DNA-free
kit (Life Technologies). The ﬁrst-strand cDNA was synthe-sized using High Capacity RNA-to-cDNA Kit (Life Tech-
nologies). The resulting cDNAs served as templates for
RT-qPCR proﬁling. PCR reaction mixtures for individual
samples were transferred into the loading port on the cus-
tomized TLDA cards (mature miRNA card, or precursor
miRNA card), and loaded to each well by spinning the
array card in a centrifuge according to the manufacturer’s
instructions. The card was then sealed and PCR was
performed using ViiA 7 Real-Time PCR System (Life
Technologies) with the following program: hold 2 min at
50 C, followed by 10 min at 95 C, then 40 cycles of 15 s
at 95 C and 1 min at 60 C.
Data analyses
qPCR cycle threshold (Ct) raw data were processed with ViiA
7 RUO software (Life Technologies) excluding data that
failed QC. miR-646 was removed from primary cell data
set analysis, since mature miR-646 was not expressed in rat.
We also removed the control RNU66 from the rat data set
because it was ampliﬁed poorly (data not shown). As with
the precursor panel, hsa-mir-92a-1 (precursor for miR-20a)
was also excluded from analysis due to inefﬁcient PCR ampli-
ﬁcation in all samples. Data from different array cards were
then pooled for further analysis using DataAssist software
(Life Technologies). Averaged internal controls (U6 with or
without RNU66 for mature miRNA cards, and beta-actin
Table 3 Relative expression of miRNA precursors in the human brain tissue
Precursor Fold change P value
hsa-let-7a-1-Hs03302533_pri 0.793 0.8655
hsa-mir-103a-1-Hs03302763_pri 0.714 0.835
hsa-mir-103a-2-Hs03302758_pri 0.318 0.0527
hsa-miR-107-Hs03302781_pri 1.200 0.9711
hsa-miR-124-1-Hs03303077_pri 585.700 0.0002
hsa-miR-143-Hs03303166_pri 0.072 0.0008
hsa-miR-15a-Hs03302582_pri 1.550 0.7661
hsa-miR-15b-Hs03294999_pri 0.424 0.1393
hsa-miR-16-2-Hs03303046_pri 0.181 0.0161
hsa-miR-195-Hs03303320_pri 0.917 0.9711
hsa-miR-23a-Hs03294931_pri 0.036 0.0000
hsa-miR-27b-Hs03303051_pri 0.741 0.8575
hsa-miR-29a-Hs03302672_pri 0.284 0.4629
hsa-miR-29b-1-Hs03302748_pri 0.971 0.9711
hsa-miR-29c-Hs04225365_pri 1.720 0.835
hsa-miR-30d-Hs03302839_pri 0.341 0.1045
hsa-miR-320a-Hs03303331_pri 0.980 0.9711
hsa-miR-424-Hs03303697_pri 0.228 0.0527
hsa-miR-497-Hs03303903_pri 0.781 0.8655
hsa-miR-503-Hs03304160_pri 0.210 0.0463
hsa-miR-646-Hs03304793_pri 0.223 0.0377
Note: Expression of miRNA precursors in human brain tissue is normalized to that in non-brain tissues and presented as fold change. Expression
that is signiﬁcantly higher or lower in brain is highlighted in red and green, respectively (P < 0.05). Members of miR-15/107 family are highlighted
in blue.
28 Genomics Proteomics Bioinformatics 12 (2014) 19–30and GAPDH for precursor miRNA cards) were used to cal-
culate dCt (DCt) values of a given sample in relative to a se-
lected reference sample. We found that endogenous genes are
expressed differently across various tissues, making them
inappropriate as internal controls, so instead of using the
internal controls to normalize among various tissues, we used
Global Mean normalization [48] to normalize the pooled
dataset. miRNAs were considered undetectable with Ct
valueP 35 (mature miRNAs) or 40 (precursor miRNAs).
Relative expression levels of mature miRNA or miRNA pre-
cursor were presented as fold change over a selected reference
sample (e.g., cerebral cortex).
Level of miRNA expression was evaluated using unpaired
Student t-test and multiple testing using Benjamin-Hochberg
false discovery rate (FDR) method was applied to correct
the reported P values. P< 0.05 was considered as statistically
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Table 4 Expression correlation between mature and precursor
miRNAs in human tissues
miRNA Correlation coeﬃcient (R2)
hsa-let-7a 0.6229
hsa-miR-103-1 0.4655
hsa-miR-103-2 0.8357
hsa-miR-107 0.7086
hsa-miR-124a 0.9189
hsa-miR-143 0.1328
hsa-miR-15a 0.0569
hsa-miR-15b 0.0129
hsa-miR-16 0.1339
hsa-miR-195 0.3062
hsa-miR-23a 0.4538
hsa-miR-27a 0.5116
hsa-miR-27b 0.5003
hsa-miR-29a 0.3473
hsa-miR-29b 0.7067
hsa-miR-29c 0.5706
hsa-miR-30d 0.3161
hsa-miR-320 0.4067
hsa-miR-424 0.1683
hsa-miR-497 0.4361
hsa-miR-503 0.0273
hsa-miR-646 0.0023
Note: Relative expression levels of mature and precursor miRNAs in
various human tissues were presented in Figure S1 and the correlation
coefﬁcient (R2) were obtained by linear regression test. Members of
miR-15/107 family are highlighted in bold.
Table 5 Relative expression of miR-103 precursors in different
tissues
Tissue
Ct value
Fold change
hsa-miR-
103a-1
hsa-miR-
103a-2
Cerebral
cortex
27.4 26.6 1.8
Frontal cortex 28.7 26.9 3.6
Heart 32.4 30.0 5.4
Kidney 35.9 31.2 24.8
Lung 31.8 28.9 7.2
Liver 34.3 31.7 5.8
Primary vision
cortex
29.4 27.2 4.6
Skeletal muscle 32.3 30.9 2.7
Spleen 38.4 32.2 72.8
Stomach 32.5 31.5 2.1
Thymus 31.5 29.2 5.0
Note: Expression levels of two miR-103 precursors were presented as
cycle threshold (Ct) or expressed as fold change. Fold change is cal-
culated as 2(Ct2Ct1), where Ct1 and Ct2 refers to the Ct value of has-
miR-103a-1 and has-miR-103a-2, respectively.
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